
Psilocybin-assisted therapy shows potential to help people quit smoking
A BBC Health report describes a randomized trial where a single high dose of psilocybin (about 30 mg, with 10 CBT sessions) plus talk therapy led to significantly higher smoking cessation than nicotine patches: 52% abstinent at six months in 82 participants vs 25% in the patch group. These findings, echoing earlier smaller studies, suggest psychedelics can trigger neuroplastic changes and a shift in priorities that support quitting, and are driving a larger NIH-funded, multi-site follow-up study to confirm efficacy and understand mechanisms. However, experts caution the sample was small and not highly diverse, so results may not generalize, and long-term safety and durability remain to be seen.













